drugset / Trial / NCT03953170
Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications
Phase 3
Withdrawn
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Shire · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the study is to investigate the natural history of patients with a temporary ileostomy and to assess the effect of Teduglutide in reducing morbidity, hospital readmissions and post reversal complications.
Timeline
- Start
- 2022-06-02
- Primary completion
- 2022-11-25
- Completion
- 2022-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Teduglutide | Peptide | 0.05 g/kg | Subcutaneous |
Indications
No indication recorded.